Evidence map›Paper›PMID 38348455›Full record

ReviewBone reports2024

Osseous implications of proton pump inhibitor therapy: An umbrella review.

Abdullah S Alanazi, Hadiah Almutairi, Jeetendra Kumar Gupta, Dibyalochan Mohanty, Deepankar Rath, Ali A AlOdan, Ahmed Mahal, Mahalaqua Nazli Khatib, Shilpa Gaidhane, Quazi Syed Zahiruddin and 3 more

Open access · goldAbstract readReview
In one paragraph

Review in Bone reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 4 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 12 institutions in 4 countries.

Abdullah S AlanaziDepartment of Clinical Pharmacy, College of Pharmacy, Jouf University, Al-Jouf, Saudi Arabia.
Hadiah AlmutairiDepartment of Pharmacy Practice, College of Pharmacy, University of Hafr Albatin, Saudi Arabia.
Jeetendra Kumar GuptaInstitute of Pharmaceutical Research, GLA University Mathura, Uttar Pradesh, India.
Dibyalochan MohantyCentre for Nano Medicine, Department of Pharmaceutics, School of Pharmacy, Anurag University, Hyderabad, India.
Deepankar RathDepartment of Pharmacology, School of Pharmacy and Life Sciences, Centurion University of Technology and Management, Odisha, India.
Ali A AlOdanDepartment of Family Medicine, Security Forces Hospital, Riyadh, Saudi Arabia.
Ahmed MahalDepartment of Medical Biochemical Analysis, College of Health Technology, Cihan University-Erbil, Erbil, Kurdistan Region, Iraq.
Mahalaqua Nazli KhatibDivision of Evidence Synthesis, Global Consortium of Public Health and Research, Datta Meghe Institute of Higher Education, Wardha, India.
Shilpa GaidhaneOne Health Centre (COHERD), Jawaharlal Nehru Medical College, Datta Meghe Institute of Higher Education, Wardha, India.
Quazi Syed ZahiruddinSouth Asia Infant Feeding Research Network (SAIFRN), Division of Evidence Synthesis, Global Consortium of Public Health and Research, Datta Meghe Institute of Higher Education, Wardha, India.
Sarvesh RustagiSchool of Applied and Life Sciences, Uttaranchal University, Dehradun, Uttarakhand, India.
Prakasini SatapathyCenter for Global Health Research, Saveetha Medical College and Hospital, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, India.
Hashem Abu SerhanDepartment of Ophthalmology, Hamad Medical Corporation, Doha, Qatar.
Datta Meghe Institute of Medical Sciences · INAdvanced Numerical Research and Analysis Group · INAl Jouf University · SACenturion University of Technology and Management · INCihan University-Erbil · IQGLA University · INGraphic Era University · INHamad Medical Corporation · QAJawaharlal Nehru Medical College · INSecurity Forces Hospital · SAUniversity of Hafr Al-Batin · SAUttaranchal University · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Proton pump inhibitors (PPIs) are among the most commonly prescribed medications worldwide for acid-related disorders. While their short-term efficacy and safety are well-established, concerns regarding their long-term effects on bone health have emerged. This umbrella review aimed to synthesize the available findings on the associations between PPI use and bone metabolism outcomes. Methods: An electronic search was conducted using PubMed, Web of Science, Embase, and the Cochrane Database up to September 16, 2023. Systematic reviews and meta-analyses of randomized controlled trials (RCTs) and observational studies that evaluated the relationship between PPIs and bone metabolism outcomes were included. Data extraction, quality appraisal, and synthesis were performed in line with the Joanna Briggs Institute and PRISMA guidelines. The strength of the evidence was graded using the GRADE criteria. Statistical analysis was performed in R version 4.3. Results: Out of 299 records, 27 studies met the inclusion criteria. The evidence indicated a statistically significant increased risk of fractures, notably hip, spine, and wrist fractures, in PPI users. PPI use was associated with changes in Bone Mineral Density (BMD) across various bones, though the clinical relevance of these changes remains uncertain. Furthermore, PPI-induced hypomagnesemia, which can influence bone health, was identified. A notable finding was the increased risk of dental implant failures in PPI users. However, the certainty of most of the evidence ranged from very low to low based on GRADE criteria. Conclusion: The long-term use of PPIs may be associated with adverse bone health outcomes, including increased fracture risk, alterations in BMD, hypomagnesemia, and dental implant failure. While these findings highlight potential concerns for long-term PPI users, the current evidence's low certainty underscores the need for robust, high-quality research to clarify these associations.

Indexed as

Bone healthBone mineral densityFracture riskMeta-analysisProton pump inhibitors

Identifiers

PMID38348455
PMCPMC10859261
OpenAlexW4391671677

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.